(Reuters) -Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
The company expects adjusted profit per share for fiscal 2025 to be between $8.15 and $8.20, compared with previously forecast range of $8.05 to $8.15.
Analysts on average expect 2025 profit to be $8.13 per share, according to data compiled by LSEG.
The company also issued preliminary forecast for fiscal 2026 adjusted profit per share at $9.10 to $9.30, while analysts’ estimate $9.12.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shilpi Majumdar)
Comments